| 000 | 01538 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513091857.0 | ||
| 264 | 0 | _c19960806 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMars, W M | |
| 245 | 0 | 0 |
_aPresence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. _h[electronic resource] |
| 260 |
_bCancer research _cJun 1996 |
||
| 300 |
_a2837-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCulture Media, Serum-Free |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aHepatocyte Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aLiver _xcytology |
| 650 | 0 | 4 |
_aPlasminogen Activators _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xmetabolism |
| 650 | 0 | 4 |
_aTransforming Growth Factor alpha _xpharmacology |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
| 650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xantagonists & inhibitors |
| 700 | 1 | _aKim, T H | |
| 700 | 1 | _aStolz, D B | |
| 700 | 1 | _aLiu, M L | |
| 700 | 1 | _aMichalopoulos, G K | |
| 773 | 0 |
_tCancer research _gvol. 56 _gno. 12 _gp. 2837-43 |
|
| 999 |
_c8663841 _d8663841 |
||